HES
42
2
KO
59
4
EQT
59
2
GME
86
5
LLY
56
9
EXPE
72
-9
CVS
58
-2
FOXA
53
-11
ADM
42
5
NSC
73
23
AEE
69
-2
FE
64
-2
HUM
34
-2
MLM
53
-4
MAT
52
-3
FRT
50
-6
AZO
58
-2
C
72
-2
BDX
25
2
MSI
44
-3
HES
42
2
KO
59
4
EQT
59
2
GME
86
5
LLY
56
9
EXPE
72
-9
CVS
58
-2
FOXA
53
-11
ADM
42
5
NSC
73
23
AEE
69
-2
FE
64
-2
HUM
34
-2
MLM
53
-4
MAT
52
-3
FRT
50
-6
AZO
58
-2
C
72
-2
BDX
25
2
MSI
44
-3
Financhill
Back

Perspective Therapeutics Stock Predictions

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
34

CATX
Perspective Therapeutics

Last Price:
$2.3300
Seasonality Move:
0.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Perspective Therapeutics Stock Forecast

  • Is Perspective Therapeutics Stock Undervalued?
    The current Perspective Therapeutics [CATX] share price is $2.3500. The Score for CATX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Perspective Therapeutics Stock Go Up Next Year?

Data Unavailable

Perspective Therapeutics Stock Rating

Data Unavailable

Perspective Therapeutics Stock Price History

Is CATX stock going to rise?

  • The current trend is relatively stagnant and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com

52-Week Data

52-Week High:
19.0500
52-Week Low:
1.6000

Prediction Charts

Market Cap:
174M
Price in USD:
2.3500
Volume:
364K
Beta:
-72.1030

Technical Analysis

SMA50:
2.2982
SMA100:
2.7814
SMA200:
7.1264
52-Wk Change:
-86.94%

Stock Predictions

  • Is Perspective Therapeutics stock public?
    Yes, Perspective Therapeutics is a publicly traded company.
  • What is the Perspective Therapeutics stock quote today?
    The Perspective Therapeutics stock price is 2.3500 USD today.
  • How to buy Perspective Therapeutics stock online?
    You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-22 1.9500 2.1400 2.1500 1.9300
Apr-23 2.2300 2.3300 2.4100 2.2300
Apr-24 2.3600 2.4300 2.4400 2.2800
Apr-25 2.4200 2.3900 2.4500 2.3300
Apr-28 2.3900 2.4500 2.4700 2.3550
Apr-29 2.4600 2.4100 2.4800 2.3250
Apr-30 2.3700 2.4500 2.4650 2.3050
May-1 2.4500 2.4700 2.4900 2.3650
May-2 2.5000 2.5600 2.6490 2.4900
May-5 2.5500 2.4300 2.6000 2.4000
May-6 2.4000 2.2400 2.4000 2.1800
May-7 2.3300 2.3500 2.3500 2.2400
May-8 2.3500 2.4200 2.4500 2.2700
May-9 2.4200 2.3500 2.4900 2.3200

Perspective Therapeutics Earnings

Data Unavailable

Perspective Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.37 per share, and a decrease next year of $0.20 per share.

* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.